[Interaction between misoprostol and acenocoumarol]. 1995

M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret

UI MeSH Term Description Entries
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074 Acenocoumarol A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233) Acenocoumarin,Nicoumalone,Mini-Sintrom,Sinkumar,Sinthrome,Sintrom,Syncoumar,Syncumar,Synthrom,Mini Sintrom,MiniSintrom
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016595 Misoprostol A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. Apo-Misoprostol,Cytotec,Glefos,Misoprostol, (11alpha,13E)-Isomer,Misoprostol, (11alpha,13E,16R)-Isomer,Misoprostol, (11alpha,13Z)-(+-)-Isomer,Misoprostol, (11alpha.13E,16S)-Isomer,Misoprostol, (11beta,13E)-(+-)-Isomer,Misoprostol, (11beta,13E,16R)-Isomer,Misoprostol, (11beta,13E,16S)-Isomer,Novo-Misoprostol,SC-29333,SC-30249,Apo Misoprostol,Novo Misoprostol,SC 29333,SC 30249,SC29333,SC30249

Related Publications

M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
December 2012, European journal of clinical pharmacology,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
March 2013, European journal of clinical pharmacology,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
January 1997, The Annals of pharmacotherapy,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
June 1996, British journal of clinical pharmacology,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
January 2011, Antiviral therapy,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
February 2002, The Annals of pharmacotherapy,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
September 2017, The Journal of the Association of Physicians of India,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
April 2002, The Annals of pharmacotherapy,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
January 2001, Therapie,
M P Martin, and A P Jonville-Bera, and F Bera, and X Caillard, and E Autret
May 1997, Medicina clinica,
Copied contents to your clipboard!